Boca Raton, FL -- (SBWIRE) -- 09/20/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners.StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks –Genco Shipping & Trading Limited(NYSE:GNK), Eagle Bulk Shipping Inc.(NASDAQ:EGLE), Acceleron Pharma Inc(NASDAQ:XLRN),Organovo Holdings Inc(NYSEMKT:ONVO)
Genco Shipping & Trading Limited(NYSE:GNK) reported the gain of 10.05% and closed at $4.38 with the total traded volume of 7.17 million shares. Its market capitalization is $ 194.74million. The stock has a 52-week high price of $4.98and its 52-week low was recorded at $1.12
Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels. As of December 31, 2012, GS&T’s fleet consisted of 53 drybulk carriers, including nine capesize, eight panamax, 17 supramax, six handymax and 13 handysize drybulk carriers, with an aggregate carrying capacity of approximately 3,810,000 deadweight tonnages.
What GNK Charts Are Signaling for Traders? Find Out Here
Eagle Bulk Shipping Inc.(NASDAQ:EGLE) gained 30.74% and ended at $7.06.The total traded volume was 5.53 million shares and market capitalization arrived at $117.61M. The stock has a 52-week high price of $7.13and its 52-week low was recorded at $1.32, while during last trade its minimum price was $5.51 and it gained the highest price of $7.13.
Eagle Bulk Shipping Inc. is engaged primarily in the ocean transportation of a range of major and minor bulk cargoes, including iron ore, coal, grain, cement and fertilizer, along worldwide shipping routes. The Company operates in the Handymax sector of the dry bulk industry, with particular emphasis on the Supramax class of vessels.
Is EGLE Buy After The Recent Price Movement? Find Out Here
Acceleron Pharma Inc(NASDAQ:XLRN)’s reported gain 33.27% and close at $19.99 with the overall traded volume of 5.52M shares. Its market capitalization on last close reached to $1.79 billion. The company has the total of 435.29M outstanding shares. Its intraday-low price was $18.50and its hit its day's highest price at $20.80.
Acceleron Pharma Inc. is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company’s research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body.
Should XLRN a Buy or Sell Now? Find Out Here
Organovo Holdings Inc(NYSEMKT:ONVO) increase 8.26% settle at $6.03. Its total traded volume during last trading session was 5.37 million shares. The overall market worth of this company is about $461.34 billion. The 52 week range of the stock remained $1.80 - $8.50, while its day's lowest price was $5.80 and its hit its day's highest price at $6.20.
Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development,
What ONVO Charts Are Signaling for Traders? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)